معرفی
Bilal Zulfiqar is a Postdoctoral Research Fellow in Discovery Biology at Griffith University's School of Environment and Science. He specializes in drug discovery for neglected tropical diseases, particularly leishmaniasis and Chagas disease, leveraging high-content imaging and high-throughput screening techniques. His work focuses on developing multiplexed assays for cytological and phenotypic profiling of novel therapeutics.
Education:
- Pharm.D. (Doctor of Pharmacy), Hamdard University, Pakistan (2008)
- M.Phil. in Virology and Immunology, National University of Sciences and Technology (NUST), Pakistan (2011)
- Ph.D. in Pharmacology/Drug Discovery, Griffith University, Australia (2014–2018)
Research Interests: Drug discovery for kinetoplastid infections, high-throughput screening methodologies, cancer immunotherapy, and the application of nanomedicine in biomedical research. His work bridges basic science and translational research, aiming to address unmet clinical needs in infectious and oncological diseases.
Publications: Bilal has contributed to over 20 peer-reviewed articles, including seminal work on leishmaniasis drug discovery assays and preclinical candidates like DNDI-6174. His research highlights include the development of novel anti-Giardia compounds and the evaluation of amiodarone in Chagas disease contexts.
Awards:
- 2020 Griffith Institute RICE Award for Excellence in Research
- 2017 SLAS Best Academic Poster Award (Washington, D.C.)
- Multiple travel grants supporting global research collaborations
Advising & Grants: Currently serves as an associate supervisor for Griffith University doctoral and master’s projects focused on natural product-derived trypanocidal compounds. His research has been supported by DNDi collaborations and institutional grants.
Labs/Teams: A core member of the Discovery Biology team at Griffith, collaborating with global networks like the Drugs for Neglected Diseases Initiative (DNDi) to advance drug pipelines for neglected diseases.
